Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Induction of sustained deep molecular response in a patient with chronic-phase T315I-mutated chronic myeloid leukemia with interferon-α monotherapy.

× No keyword cloud information.

6 in total

Review 1. Immunology and immunotherapy of chronic myeloid leukemia.

Authors: Mette Ilander; Can Hekim; Satu Mustjoki
Journal: Curr Hematol Malig Rep Date: 2014-03 Impact factor: 3.952

2. Terminal deletion of 11q with significant late-onset combined immune deficiency.

Authors: Mikko Seppänen; Hannele Koillinen; Satu Mustjoki; Mölkänen Tomi; Kathleen E Sullivan
Journal: J Clin Immunol Date: 2014-01 Impact factor: 8.317

Review 3. Improving outcomes in chronic myeloid leukemia through harnessing the immunological landscape.

Authors: Ya-Ching Hsieh; Kristina Kirschner; Mhairi Copland
Journal: Leukemia Date: 2021-04-08 Impact factor: 12.883

Review 4. B-Lymphoid Blast Phase-Chronic Myeloid Leukemia: Current Therapeutics.

Authors: Binoy Yohannan; Binsah George
Journal: Int J Mol Sci Date: 2022-10-05 Impact factor: 6.208

5. Enlarged memory T-cell pool and enhanced Th1-type responses in chronic myeloid leukemia patients who have successfully discontinued IFN-α monotherapy.

Authors: Mette Ilander; Anna Kreutzman; Peter Rohon; Teresa Melo; Edgar Faber; Kimmo Porkka; Jukka Vakkila; Satu Mustjoki
Journal: PLoS One Date: 2014-01-31 Impact factor: 3.240

6. Interferon-α Revisited: Individualized Treatment Management Eased the Selective Pressure of Tyrosine Kinase Inhibitors on BCR-ABL1 Mutations Resulting in a Molecular Response in High-Risk CML Patients.

Authors: Vaclava Polivkova; Peter Rohon; Hana Klamova; Olga Cerna; Martina Divoka; Nikola Curik; Jan Zach; Martin Novak; Iuri Marinov; Simona Soverini; Edgar Faber; Katerina Machova Polakova
Journal: PLoS One Date: 2016-05-23 Impact factor: 3.240

6 in total